J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 7,670.00
-350.00 (-4.36%)
At close: Nov 6, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 44.85 billion as of November 5, 2026. It is the 32,627th most valuable company in the world and the 1,825th biggest in South Korea. Its market cap has decreased by 6.58% in one year.
Market Cap
44.85B
Enterprise Value
35.99B
Revenue
43.90B
Global Rank
Country Rank
#1,825 South Korea
PE Ratio
7.71
ChartMarket Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 44.85B, a decrease of -69.05%. That is a compound annual growth rate of -36.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 44.85B | -10.81% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 57.82B |
| PanGen Biotech | 55.41B |
| TegoScience | 53.72B |
| KoBioLabs | 51.46B |
| Psomagen | 51.36B |
| NovMetaPharma | 50.72B |
| Epibiotech | 48.21B |
| QuadMedicine | 47.71B |